2 results
Approved WMOCompleted
To gain information about the characteristics of the oVEMP response in patients with BRIC type 1
Approved WMOCompleted
The primary objective is to compare PFS after treatment with tabalumab, bortezomib, anddexamethasone to that of placebo, bortezomib, and dexamethasone in patients with relapsed/refractory MM.Secondary objectives will include comparison of treatment…